Topical treatment with nerve growth factor for corneal neurotrophic ulcers

The New England Journal of Medicine
A LambiaseL Aloe

Abstract

Corneal neurotrophic ulcers associated with impairment of sensory innervation of the cornea may lead to loss of vision, and there is no effective treatment for these ulcers. We evaluated the effects of nerve growth factor in patients with this disorder. Twelve patients (14 eyes) with severe neurotrophic corneal ulcers associated with corneal anesthesia were treated with topical nerve growth factor 10 times daily for two days and then 6 times daily until the ulcers healed. Treatment continued for 2 weeks after the ulcers healed, and the patients were then followed for up to 12 months. The evolution of the corneal disease during treatment and follow-up was evaluated by slit-lamp examination, photography, fluorescein-dye testing, and tests of corneal sensitivity and best corrected visual acuity. Corneal healing began 2 to 14 days after the initiation of treatment with nerve growth factor, and all patients had complete healing of their corneal ulcers after 10 days to 6 weeks of treatment. Corneal sensitivity improved in 13 eyes, and returned to normal in 2 of the 13 eyes. Corneal integrity and sensitivity were maintained during the follow-up period (range, 3 to 12 months). Best corrected visual acuity increased progressively during...Continue Reading

References

Aug 1, 1992·Journal of Neuroscience Research·T Ebendal
Sep 4, 1987·Science·R Levi-Montalcini
Dec 1, 1987·Immunological Reviews·R H SteadA M Stanisz
Aug 22, 1968·The New England Journal of Medicine·D L Epstein, D Paton
Mar 22, 1974·Annals of the New York Academy of Sciences·T W MittagJ P Green
Oct 1, 1969·Proceedings of the National Academy of Sciences of the United States of America·V Bocchini, P U Angeletti
Jul 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·A K LiM Young
Jul 1, 1980·Experimental Neurology·R W Beuerman, B Schimmelpfennig
Jul 9, 1994·Lancet·P AnandR E Williams-Chestnut
Nov 1, 1994·Archives of Ophthalmology·K TervoT M Tervo
Nov 1, 1993·Experimental Neurology·L Olson
Apr 1, 1993·Neuroreport·K M MearowJ Diamond
Mar 29, 1996·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·P Anand
Jun 1, 1996·Progress in Neurobiology·S S Riaz, D R Tomlinson
Oct 1, 1995·Ophthalmology·V Puangsricharern, S C Tseng
Jul 1, 1954·A.M.A. Archives of Ophthalmology·S SIGELMAN, J S FRIEDENWALD
Jun 1, 1926·The British Journal of Ophthalmology·L Paton

❮ Previous
Next ❯

Citations

Nov 13, 2004·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·C CursiefenF E Kruse
Dec 29, 2004·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·B SeitzF E Kruse
Oct 9, 2009·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·J D UnterlauftG Geerling
Sep 15, 2005·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Marco CoassinStefano Bonini
Jan 16, 2007·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Thomas FuchslugerDaniel Meller
May 5, 2007·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Alessandro LambiaseStefano Bonini
Oct 19, 2011·Neurosurgical Review·Ulf WesterlundTiit Mathiesen
Sep 6, 2007·International Ophthalmology·Samar A Al-Swailem
Jan 7, 2004·Biochemical and Biophysical Research Communications·Akane TanakaHiroshi Matsuda
Nov 12, 2003·Survey of Ophthalmology·Martin GrueterichScheffer C G Tseng
Jul 13, 2000·Ophthalmology·J L Baum
Feb 26, 2000·Trends in Pharmacological Sciences·H U Saragovi, K Gehring
May 16, 2002·Neurobiology of Aging·Grazyna NiewiadomskaMarta Baksalerska-Pazera
Sep 2, 2003·Cytokine & Growth Factor Reviews·Alessandra MiceraFrancesca Levi-Schaffer
Nov 30, 2006·The Ocular Surface·Kenneth Mark Goins
Oct 11, 2005·Eye·A LockwoodP Chell
Apr 29, 1998·The New England Journal of Medicine·R E Smith, A A Sadun
Oct 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Alessandro LambiaseRita Levi-Montalcini
Jul 25, 2000·The British Journal of Ophthalmology·H J ChenS C Tseng
Jan 8, 2009·Physiological Reviews·Andrea Caporali, Costanza Emanueli
Nov 30, 2012·Journal of Translational Medicine·Luigi AloeLuigi Manni
Apr 23, 2008·Pediatric Research·Ajay ShahElizabeth Orwin
Jun 5, 2001·Clinical Chemistry and Laboratory Medicine : CCLM·S C Apfel
Jun 28, 2013·American Journal of Veterinary Research·Chelsey MillerJill Beech
Apr 13, 2013·Middle East African Journal of Ophthalmology·Pho Nguyen, Samuel C Yiu
Dec 9, 2003·Proceedings of the National Academy of Sciences of the United States of America·Fengfu LiMay Griffith
May 16, 2006·Journal of Endocrinological Investigation·P TotiF Petraglia
Dec 13, 2005·Proceedings of the National Academy of Sciences of the United States of America·Anna M ColangeloRita Levi-Montalcini
Mar 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·L CalzaR Levi-Montalcini
Dec 12, 2013·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Mauro P FerrariAlessandro Lambiase

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.